Ds. Pisetsky et Cf. Reich, Influence of backbone chemistry on immune activation by synthetic oligonucleotides, BIOCH PHARM, 58(12), 1999, pp. 1981-1988
Depending on base sequence, DNA displays immunological activities relevant
to the design of novel therapeutic agents. To determine the influence of ba
ckbone structure on these activities, we tested a series of synthetic phosp
hodiester and phosphorothioate oligonucleotides in in vitro cultures of mur
ine spleen cells. These compounds were 30 bases long and consisted of eithe
r a single base or an immunostimulatory sequence (AACGTT) flanked on 5' and
3' ends by 12 nucleotides of each base. Cell activation was assessed by bo
th thymidine incorporation and expression of cell surface CD69; production
of interleukin-6 and interleukin-12 was used as a measure of cytokine stimu
lation. In these assays, phosphorothioate oligonucleotides induced much hig
her levels of proliferation CD69 expression, and cytokine production than t
he comparable phosphodiester compounds and had activity at lower concentrat
ions. The sequence for optimal stimulation by phosphorothioates varied amon
g responses, however. For example, whereas compounds containing an immunost
imulatory sequence all induced similar levels of proliferation and CD69 exp
ression, cytokine production was greatest with compounds with dA and dT fla
nks. Furthermore, while single base dG oligonucleotides stimulated prolifer
ation as both phosphodiesters and phosphorothioates, they failed to stimula
te cytokine production. Together, these findings indicate that base sequenc
e as well as backbone chemistry influence immune activation by synthetic ol
igonucleotides, with the effects varying among responses. While suggesting
differences in the structure-function relationships of nucleic acids in the
ir immune activities, these findings also raise the possibility of the desi
gn of agents with specific patterns of immune modulation. (C) 1999 Elsevier
Science Inc.